Endocrine Consequences of Long-Term Intrathecal Administration of Opioids
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few data are available about possible effects on hypothalamic-pituitary function during this treatment. Seventy-three patients (29 men and 44 women; mean age, 49.2 ± 11.7 yr) receiving opioids intrathecally for nonmalignant pain were enrolled for extensive endocrine investigation. At the time of hormonal determination, the mean duration of opioid treatment was 26.6 ± 16.3 months; the mean daily dose of morphine was 4.8 ± 3.2 mg. The control group consisted of 20 patients (11 men and 9 women; mean age, 54.2 ± 14.0 yr) with a comparable pain syndrome but not treated with opioids. Decreased libido or impotency was present in 23 of 24 men receiving opioids. The serum testosterone level was below 9 nmol/L in 25 of 29 men and was significantly lower than that in the control group (P < 0.001). The free androgen index was below normal in 18 of 29 men and was significantly lower than that in the control group (P < 0.001). The serum LH level was less than 2 U/L in 20 of 29 men and was significantly lower than that in the control group (P < 0.001). Serum FSH was comparable in both groups. Decreased libido was present in 22 of 32 women receiving opioids. All 21 premenopausal females developed either amenorrhea or an irregular menstrual cycle, with ovulation in only 1. Serum LH, estradiol, and progesterone levels were lower in the opioid group. In all 18 postmenopausal females significantly decreased serum LH (P < 0.001) and FSH (P = 0.012) levels were found. The 24-h urinary free cortisol excretion was below 20 μg/day in 14 of 71 opioid patients and was significantly lower than that in the control group (P = 0.003). The peak cortisol response to insulin-induced hypoglycemia was below 180 μg/L in 9 of 61 opioid patients and was significantly lower than that in the nonopioid group (P = 0.002). The insulin-like growth factor I sd score was below −2 sd in 12 of 73 opioid patients and was significantly lower than that in the control group (P = 0.002). The peak GH response to hypoglycemia was below 3 μg/L in 9 of 62 subjects and was significantly lower than that in the control group (P = 0.010). Thyroid function tests and PRL levels were considered normal. No metabolic disturbances were recorded, apart from significantly decreased high density lipoprotein cholesterol levels (P = 0.041) and elevated total/high density lipoprotein cholesterol ratio (P = 0.008) in the opioid group compared to the control group. Supplementation with gonadal steroids improved sexual function in most patients. In conclusion, of all patients receiving intrathecal opioids, the large majority of men and all women developed hypogonadotropic hypogonadism, about 15% developed central hypocorticism, and about 15% developed GH deficiency. These findings suggest that further investigations are required to determine the need for systematic endocrine work-up in these patients and the necessity for substitutive therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A landmark study published 3 years later, investigating the effects of intrathecal opioids using the insulin tolerance test (ITT) (the gold standard for the diagnosis of secondary adrenal insufficiency), showed that 15% (9/61) of the patients on intrathecal opioids for nonmalignant pain had secondary adrenal insufficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“These results suggest that up to 17% of the patients treated with intrathecal opioids may develop GH deficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Twelve opioid-treated patients (17%) had an IGF-I SD score below -2 SD, as opposed to no such case in the control group.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Nine opioid-treated patients (15%) had a peak GH value consistent with severe GH deficiency (below 3 mcg/L), a finding not demonstrated in any control patient.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“The opioid-treated group had lower mean serum IGF-I (138.5 mcg/L ± 64.1) in comparison to the controls (162.0mcg/L ± 55.3; P = .045),as well as lower IGF-I SD score (-0.53 ± 1.45 and 0.57 ± 1.00; P = .002).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A quantitative approach to perceived health status: a validation study
Hunt, S. M., McKenna, S. P., McEwen, J., Backett, E. M., Williams, J., & Papp, E. (1980) · Journal of Epidemiology and Community Health · doi:10.1136/jech.34.4.281 · Cited by 924
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Side effects of intrathecal and epidural opioids
Chaney, M. A. (1995) · Canadian Journal of Anaesthesia · doi:10.1007/bf03011037 · Cited by 562
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
Diagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
The growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375
Winkelmüller, M., & Winkelmüller, W. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.85.3.0458 · Cited by 333
Intraspinal morphine for chronic pain: A retrospective, multicenter study
Paice, J. A., Penn, R. D., & Shott, S. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00099-2 · Cited by 302
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
The Use of Opioids for the Treatment of Chronic Pain*
&NA; (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199703000-00003 · Cited by 208
Research works printed but not linked: 1
- Gijbels, 1998, Neuromodulation of pain. A consensus statement of the European Federation of IASP Chapters (EFIC)., Eur J Pain, 2, 203
Cited by
Items 201–300 of 494
Samuel, J. B., Stanley, J. A., Sekar, P., Princess, R. A., Sebastian, M. S., & Aruldhas, M. M. (2012) · Environmental Toxicology · doi:10.1002/tox.21810 · Cited by 25
Study of morphine-induced dependence in gonadectomized male and female mice
Sadeghi, M., Sianati, S., Anaraki, D. K., Ghasemi, M., Paydar, M. J., Sharif, B., Mehr, S. E., & Dehpour, A. R. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.015 · Cited by 25
Erdine, S., & Andrés, J. A. D. (2006) · Pain Practice · doi:10.1111/j.1533-2500.2006.00059.x · Cited by 23
DÜRSTELER-MACFARLAND, K. M., KOWALEWSKI, R., BLOCH, N., WIESBECK, G. A., KRAENZLIN, M. E., & STOHLER, R. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00242.x · Cited by 22
Opioid induced adrenal insufficiency: what is new?
Donegan, D. M. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000474 · Cited by 24
Current Knowledge and Practices of Heath Care Professionals on Opioid-Induced Adrenal Insufficiency
Saeed, Z. I., Bancos, I., & Donegan, D. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0177 · Cited by 20
Wersocki, E., Bedson, J., Chen, Y., LeResche, L., & Dunn, K. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000691 · Cited by 21
Byanyima, J. I., Li, X., Vesslee, S. A., Kranzler, H. R., Shi, Z., & Wiers, C. E. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00493-4 · Cited by 22
Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction
Lue, T. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00023-2 · Cited by 27
Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
Guan, Q., Velho, R. V., Sehouli, J., & Mechsner, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021633 · Cited by 23
A Benefit/Risk Assessment of Intrathecal Ziconotide in Chronic Pain: A Narrative Review
Rubiu, E., Restelli, F., Nazzi, V., Mazzapicchi, E., Bonomo, G., Veiceschi, P., Alfiero, T., Agresta, G., Locatelli, D., & Dario, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061644 · Cited by 24
Opioid-Induced Hypogonadism in the United States
Baillargeon, J., Raji, M. A., Urban, R. J., López, D. S., Williams, S. B., Westra, J. R., & Kuo, Y. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.06.007 · Cited by 21
Duarte, R. V., Lambe, T., Raphael, J. H., Eldabe, S. S., & Andronis, L. (2017) · Pain Practice · doi:10.1111/papr.12650 · Cited by 21
Pharmacology of intrathecally administered agents for treatment of spasticity and pain
Hayek, S. M., Joseph, P. N., & Mekhail, N. A. (2003) · Seminars in Pain Medicine · doi:10.1016/j.spmd.2004.02.002 · Cited by 21
Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate
Ioannidou-Kadis, S., Wright, P. J., Neely, R. D. G., & Quinton, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.065 · Cited by 26
Topics in Neuromodulation Treatment
Carrillo-Ruiz, J. D. (2012) · InTech eBooks · doi:10.5772/1255 · Cited by 20
Brief review: Pain management for cancer survivors: challenges and opportunities
Yazdani, S., & Abdi, S. (2014) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0170-5 · Cited by 20
Birke, H., Ekholm, O., Højsted, J., Sjøgren, P., & Kurita, G. P. (2018) · Pain Medicine · doi:10.1093/pm/pny122 · Cited by 23
Pain-Relief Medication and Risk of Fractures
Vestergaard, P. (2008) · Current Drug Safety · doi:10.2174/157488608785699504 · Cited by 20
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Manfredi, P. L. (2003) · Neurology · doi:10.1212/wnl.60.6.1052-a · Cited by 20
Intrathecal drug delivery for chronic pain management-scope, limitations and future
Czernicki, M., Sinovich, G., Mihaylov, I. R., Nejad, B., Kunnumpurath, S., Kodumudi, G., & Vadivelu, N. (2014) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-014-9607-1 · Cited by 19
Aloisi, A. M., Vodo, S., & Buonocore, M. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1440-7 · Cited by 22
Functional Outcomes in Patients with Chronic Nonmalignant Pain on Long‐Term Opioid Therapy
Soin, A., Cheng, J., Brown, L. L., Moufawad, S., & Mekhail, N. A. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00233.x · Cited by 19
Major Opioids and Chronic Opioid Therapy
Cortazzo, M. H., Copenhaver, D. J., & Fishman, S. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08340-9.00036-0 · Cited by 21
Intrathecal pain management: a team-based approach
Adler, J. A., & Lotz, N. M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s142147 · Cited by 19
Effects of morphine on testosterone levels in rat C6 glioma cells: Modulation by anastrozole
Ceccarelli, I., Rossi, A., Maddalena, M., Weber, E., & Aloisi, A. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21830 · Cited by 21
Patients with chronic pain and abnormal pituitary function require investigation
Merza, Z., Edwards, N., Walters, S., Newell-Price, J., & Ross, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13775-0 · Cited by 18
Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem
Buss, T., & Leppert, W. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0096-x · Cited by 20
A safety review of approved intrathecal analgesics for chronic pain management
Chalil, A., Staudt, M. D., Harland, T., Leimer, E. M., Bhullar, R. K., & Argoff, C. E. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1889513 · Cited by 20
Verdi, J., & Ahmadiani, A. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.02.008 · Cited by 18
Matsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 27
Matsumoto, A. M., & Bremner, W. J. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00019-5 · Cited by 18
Opioids for persistent noncancer pain.
McCleane, G., & Smith, H. S. (2007) · The Medical clinics of North America · doi:10.1016/j.mcna.2006.10.013 · Cited by 24
Corsi, D. J., & Murphy, M. S. Q. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13577 · Cited by 17
Chronic pain management issues in the primary care setting and the utility of long-acting opioids
Zorba Paster, R. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.491510 · Cited by 17
Androgen Deficiency in Long-Term Intrathecal Opioid Administration
Kim, C., Garcia, R., Stover, J., Ritchie, K., Whealton, T., & Ata, M. A. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/e543 · Cited by 17
Opioid-induced Androgen Deficiency Discussion in Opioid Contracts
Daniell, H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.027 · Cited by 17
Eldabe, S. S., Duarte, R. V., Thomson, S., Bojanić, S., Farquhar-Smith, P. W., Bagchi, S., Farquhar, L., Wetherill, B., & Copley, S. (2024) · British Journal of Pain · doi:10.1177/20494637241280356 · Cited by 16
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_18 · Cited by 23
Effects of acupuncture for cancer pain and quality of life – a case series
Vinjamury, S. P., Li, J.-T., Hsiao, E., Huang, C., Hawk, C., Miller, J. N., & Huang, Y. (2013) · Chinese Medicine · doi:10.1186/1749-8546-8-15 · Cited by 19
Rajagopal, A., & Bruera, E. D. (2003) · Pain Medicine · doi:10.1111/j.1526-4637.2003.03041.x · Cited by 16
Opioid Contribution to Decreased Cortisol Levels in Critical Care Patients
Daniell, H. W. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.12.1147 · Cited by 15
Finch, P. M., Price, L. M., Pullan, P. T., & Drummond, P. D. (2015) · Pain Practice · doi:10.1111/papr.12190 · Cited by 15
Impact of opioid therapy on gonadal hormones: focus on buprenorphine
Varma, A., Sapra, M., & Iranmanesh, A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0080 · Cited by 15
Diamanti‐Kandarakis, E., Duntas, L. H., Kanakis, G., Kandaraki, E., Karavitaki, N., Kassi, E. N., Livadas, S., Mastorakos, G. P., Migdalis, I. N., Miras, A. D., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0154 · Cited by 16
Hofford, R. S., Wellman, P. J., & Eitan, S. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.008 · Cited by 17
Morphine Inhibited the Rat Neural Stem Cell Proliferation Rate by Increasing Neuro Steroid Genesis
Feizy, N., Nourazarian, A., Rahbarghazi, R., Charoudeh, H. N., Abdyazdani, N., Montazersaheb, S., & Narimani, M. R. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1847-7 · Cited by 15
Role of progestins with partial antiandrogenic effects
Sitruk-Ware, R. L., Husmann, F., Thijssen, J. H. H., Skouby, S. O., Fruzzetti, F., Hanker, J. P., Huber, J., & Druckmann, R. A. (2004) · Climacteric · doi:10.1080/13697130400001307 · Cited by 16
Opioid-induced androgen deficiency
Daniell, H. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224806.08824.dc · Cited by 17
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Flannagan, K. S. J., Sjaarda, L. A., Mumford, S. L., & Schisterman, E. F. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa007 · Cited by 14
Effects of opioids on reproduction in Japanese medaka, Oryzias latipes
Fischer, A. J., Kerr, L., Sultana, T., & Metcalfe, C. D. (2021) · Aquatic Toxicology · doi:10.1016/j.aquatox.2021.105873 · Cited by 14
Fleming, M. P., & Paice, J. A. (2001) · Journal of Sex Education and Therapy · doi:10.1080/01614576.2001.11074415 · Cited by 14
Opioid-induced adrenal insufficiency: diagnostic and management considerations
Patel, E., & Ben-Shlomo, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280603 · Cited by 13
Hayes, C., Jordan, M., Hodson, F., & Ritchard, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049124 · Cited by 15
Shuey, D. L., Stump, D. G., Carliss, R. D., & Gerson, R. J. (2007) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20138 · Cited by 13
Persistent Hiccup Associated with Intrathecal Morphine Infusion Pump Therapy
Ruan, X., Couch, J. P., Shah, R. V., Wang, F., & Liu, H. N. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31815206c8 · Cited by 13
Bakare, T. T., Uzoeto, H. O., Gonlepa, L. N., Cosmas, S., Ajima, J. N., Arazu, A. V., Ezechukwu, S. P., Didiugwu, C. M., Ibiang, G. O., Osotuyi, A. G., et al. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03207-1 · Cited by 14
Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men
Goletiani, N. V., Mendelson, J. H., Sholar, M. B., Siegel, A. J., & Mello, N. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.007 · Cited by 13
Serum Biochemical Parameters Following Heroin Withdrawal: An Exploratory Study
Divsalar, K., Meymandi, M. S., Afarinesh, M. R., Zarandi, M. M., Haghpanah, T., Keyhanfar, F., Mahmoodi, M., & Kruszewski, S. P. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12062.x · Cited by 13
Opioid-induced hypoadrenalism resulting in fasting hypoglycaemia
Tabet, E. J., Clarke, A. J., & Twigg, S. M. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-230551 · Cited by 11
Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment
Maines, E., Urru, S. A. M., Leonardi, L., Fancellu, E., Campomori, A., Piccoli, G., Maiorana, A., Soffiati, M., & Franceschi, R. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09828-y · Cited by 13
Stress Axis in the Cancer Patient: Clinical Aspects and Management
Felicetti, F. C., Nervo, A., Gatti, F., Rosso, D., Brignardello, E., & Arvat, E. (2021) · Endocrines · doi:10.3390/endocrines2040044 · Cited by 11
Opium Consumption Challenge and Diabetes Mellitus Control
Rezvanfar, M. R., Farahany, H., Rafiee, M., & Kaboli, S. (2011) · Cited by 11
Lehtihet, M., Andersson, A., Börjesson, A., Schulze, J. J., Rane, A., Ericsson, M., & Ekström, L. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2301 · Cited by 11
Saper, J. R., & Lake, A. E. (2006) · Headache Currents · doi:10.1111/j.1743-5013.2006.00034.x · Cited by 11
Risks and benefits of long‐term intrathecal analgesia
Dickson, D. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03871.x · Cited by 11
Koman, G., Alfieri, A., Rachingter, J., Strauss, C., & Scheller, C. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/e523 · Cited by 10
Diasso, P. D. K., Frederiksen, B. S., Nielsen, S. D., Main, K. M., Sjøgren, P., & Kurita, G. P. (2021) · European Journal of Pain · doi:10.1002/ejp.1797 · Cited by 12
Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients
Diasso, P. D. K., Abou‐Kassem, D., Nielsen, S. D., Main, K. M., Sjøgren, P., & Kurita, G. P. (2023) · European Journal of Pain · doi:10.1002/ejp.2136 · Cited by 12
Sawy, M. M. E., & Malak, H. W. A. (2015) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000464775.44998.4a · Cited by 10
Pereska, Z., Bozinovska, C., Dimitrovski, Č., Petkovska, L., Chibishev, A., & Jurukov, I. (2011) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.563335 · Cited by 10
Katz, W. A. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2008.04.004 · Cited by 11
Colling, C., Nachtigall, L., Biller, B. M. K., & Miller, K. K. (2022) · Clinical Endocrinology · doi:10.1111/cen.14587 · Cited by 9
Buprenorphine-induced Symptomatic Hypogonadism in Men: Case Reports and Discussion
Colameco, S., Coren, J. S., & Zimmerman, D. J. (2008) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318172d612 · Cited by 9
Endocrine Effects of Chronic Opioid Therapy: Implications for Clinical Management
Elliott, J. A., & Fibuch, E. E. (2013) · Pain Management · doi:10.2217/pmt.13.13 · Cited by 10
Swann, S. A., King, E. M., Tognazzini, S., Campbell, A. R., Levy, S. L. A., Pick, N., Prior, J. C., Elwood, C. N., Loutfy, M. R., Nicholson, V., et al. (2023) · Viruses · doi:10.3390/v15051058 · Cited by 11
The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism
Balodimos, S., Nikolaou, K., Njau, S., Karamouzis, M., & Kovatsi, L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1068321 · Cited by 9
Chronic morphine increases the pituitary?adrenocortical response of juvenile rats to mild stress
Nock, B. L., Cicero, T. J., & Wich, M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.021 · Cited by 9
Opioids and Risk of Type 2 Diabetes in Adults with Non-Cancer Pain
Jick, S. S. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/77 · Cited by 9
Kondo, A., Murakami, T., Fujii, T., Tatsumi, M., Ueda-Sakane, Y., Ueda, Y., Yamauchi, I., Ogura, M., Taura, D., & Inagaki, N. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0359 · Cited by 11
Daniell, H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.08.014 · Cited by 9
Kafel, H., Braga‐Basaria, M., & Basaria, S. S. (2025) · Andrology · doi:10.1111/andr.70013 · Cited by 8
Effects of Intrathecal Opioid Administration on Pituitary Function
Xenidis, M. E., Pandya, N., & Hames, E. (2013) · Pain Medicine · doi:10.1111/pme.12205 · Cited by 9
Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids
Vellucci, R., Mattia, C., Celidonio, L., & Mediati, R. D. (2016) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2016.13.2.089 · Cited by 8
Effect of Long-Term Intrathecal Bupivacaine Infusion on Blood Pressure
Hayek, S. M., McEwan, M. T., Veizi, E., Roh, J., Ali, O., Katta, S., Hunter, J., Delozier, S., & Deer, T. R. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12956 · Cited by 8
Complications of intrathecal drug delivery systems
Hitt, J. M., & de León-Casasola, O. A. (2011) · Techniques in Regional Anesthesia and Pain Management · doi:10.1053/j.trap.2011.10.001 · Cited by 9
An Under-Recognized and Under-Reported Cause of Adrenal Insufficiency
Singh, N., Snyder, R. H., & Krishnamurthy, M. (2014) · International Journal of Case Reports in Medicine · doi:10.5171/2014.524907 · Cited by 8
Management of Opioid-Related Side Effects
Harris, J.-D., & Kotob, F. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7216-0261-5.50023-5 · Cited by 9
Low, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00007-1 · Cited by 9
Radiofrequency or neuromodulation treatment of chronic pain, when is it useful?
Buyten, J. P. V. (2008) · European Journal of Pain Supplements · doi:10.1016/s1754-3207(08)70067-1 · Cited by 8
Sex Hormone Deficiency in Depressed Patients Receiving Opioids
Daniell, H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.804-a · Cited by 8
Abou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_34 · Cited by 7
Consideration of gender in diagnosis and management of blood-borne viruses: the case of hepatitis C
Olsen, A., Temple-Smith, M. J., & Banwell, C. L. (2012) · Australian Journal of Primary Health · doi:10.1071/py11127 · Cited by 8
Hypogonadismus und infertilität bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2009) · Springer eBooks · doi:10.1007/978-3-540-92963-5_18 · Cited by 13
Methadone induced hypoglycemia, improved on dose adjustment
Otalora, Y., Inkollu, S., & Ursu, S. (2020) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2020.100071 · Cited by 7
Li, J., Xie, M., Yu, Y., Tang, Z., Hang, C., & Li, C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108660 · Cited by 7
Pharmacological options for low back pain
Swarm, R. A., Καρανικόλας, Μ., Rastogi, R., & Maw, M. (2004) · Seminars in Pain Medicine · doi:10.1016/j.spmd.2004.08.005 · Cited by 7
Asadikaram, G., Akbari, H., Vakili, S., Asiabanha, M., Shahrokhi, N., & Savardashtaki, A. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.466 · Cited by 7
Metadata
- Authors
- Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K.
- Affiliations
- Antwerp University Hospital (BE)
- Maria Middelares Hospital St. Niklaas (J.-P.V.B.), B-2650 Edegem, Belgium
- ZNA Middelheim Hospital (BE)
- Department of Neurosurgery, University Hospital Antwerp (J.V., T.V.H.), B-2650 Edegem, Belgium
- Department of Endocrinology, University Hospital Antwerp (R.A., K.V.A.), B-2650 Edegem, Belgium
- ORCID
- Smet, Mike
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 2215-2222
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135470636
- Cited by
- 491
- References
- 33
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 20 · 2013: 26 · 2012: 32
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- intrathecal opioids, morphine, hypothalamic-pituitary function, testosterone, free androgen index, luteinizing hormone, follicle-stimulating hormone, amenorrhea, menstrual cycle, sexual desire, erectile dysfunction, urinary free cortisol, insulin-induced hypoglycemia, cortisol response, hypothalamic-pituitary-adrenal axis, chronic non-cancer pain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Amenorrhea, Analgesics, Opioid, Androgens, Blood Pressure, Hydromorphone, Estradiol, Female, Follicle Stimulating Hormone, Hormones, Humans, Hydrocortisone, Erectile Dysfunction, Injections, Spinal, Luteinizing Hormone, Libido, Male, Middle Aged, Morphine, Pain, Intractable, Intractable Pain, Progesterone, Reference Values, Retrospective Studies, Sex Hormone-Binding Globulin, Premenopause, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.